¼¼°èÀÇ ¾Ï ´ÜŬ·ÐÇ×ü ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2033³â)
Global Cancer Monoclonal Antibodies Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
»óǰÄÚµå : 1672131
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 163 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,671,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,843,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,750,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾Ï ´ÜŬ·ÐÇ×ü ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 1,109¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2033³â¿¡´Â 5,255¾ï 7,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. 2026³â¿¡¼­ 2033³âÀÇ ¿¹Ãø ±â°£ µ¿¾È CAGR 18.87%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Ï ´ÜŬ·ÐÇ×ü ½ÃÀåÀº ¾Ï À¯º´·ü Áõ°¡¿Í Ç¥Àû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ °ßÀεǾî Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ´ÜŬ·ÐÇ×ü(mAbs)´Â ¾Ï¼¼Æ÷¸¦ ƯÀÌÀûÀ¸·Î Ç¥ÀûÀ¸·Î Çϵµ·Ï ¼³°èµÈ Àΰø ´Ü¹éÁúÀ̸ç, Á¾·¡ÀÇ È­Çпä¹ý¿¡ ºñÇØ º¸´Ù Á¤¹ÐÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÇ·á Á¦°øÀÚ¿Í È¯ÀÚ°¡ È¿°úÀûÀÌ°í µ¶¼ºÀÌ ÀûÀº Ä¡·á¹ýÀ» ¿ä±¸ÇÏ´Â °¡¿îµ¥, ¾Ï ´ÜŬ·ÐÇ×ü¿¡ ´ëÇÑ ¼ö¿ä´Â Áõ°¡Çϰí, ÀÌ ½ÃÀåÀº °ß°íÇÑ È®´ë°¡ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù. ÇöÀçÀÇ Ä¡·áÁ¦¿¡´Â Æ®¶ó½ºÅõÁÖ¸¿À̳ª ¸®Åö½Ã¸¿°ú °°Àº Á¤ÆòÀÌ ÀÖ´Â mAb ¿Ü¿¡ ´Ù¾çÇÑ ¾ÏÁ¾À» Ç¥ÀûÀ¸·Î ÇÏ´Â »õ·Î¿î ¾àÁ¦°¡ ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ´ÜŬ·ÐÇ×ü ±â¼úÀÇ Áøº¸°¡ ½ÃÀåÀÇ ±â¼ú Çõ½ÅÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌÁß Æ¯À̼º Ç×ü, Ç×ü ¾à¹° º¹ÇÕü, ¸é¿ª°ü¹®¾ïÁ¦Á¦ÀÇ °³¹ßÀº Ä¡·áÀÇ À¯È¿¼º°ú ƯÀ̼ºÀ» ³ôÀÌ´Â °ÍÀ¸·Î ¾Ï Ä¡·á¿¡ Çõ¸íÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº Ä¡·á ¼ºÀûÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇÔÀ¸·Î½á ȯÀÚÀÇ Àü¹ÝÀûÀÎ QOLÀ» Çâ»ó½Ãŵ´Ï´Ù. ´ÜŬ·ÐÇ×üÀÇ »õ·Î¿î ¿ëµµ¿Í Á¶ÇÕ ¿¬±¸°¡ ÁøÇàµÊ¿¡ µû¶ó Ä¡·á ¿É¼ÇÀÇ °³¼±ÀÌ ±â´ëµÇ±â ¶§¹®¿¡ ½ÃÀåÀº ´õ¿í È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

°Ô´Ù°¡, ¸ÂÃãÇü ÀÇ·á°¡ Áß½ÃµÇ°Ô µÇ¾î, ¾Ï ´ÜŬ·ÐÇ×üÀÇ Àü¸ÁÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á Á¦°øÀÚ´Â À¯ÀüÀÚ ¹× ºÐÀÚÀû Ư¡À» ¹ÙÅÁÀ¸·Î °³º° ȯÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ¸Â´Â Ä¡·á¸¦ ÇÏ´Â °ÍÀÇ Á߿伺À» Á¡Á¡ ÀνÄÇϰí ÀÖÀ¸¸ç, ¸ÂÃãÇü Ä¡·á Àü·«¿¡ ºÎÇÕÇÏ´Â mAb ¼ö¿ä´Â Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °æÇâÀº ƯÈ÷ µ¿¹ÝÁø´Ü°ú °ü·ÃÀÌ ÀÖÀ¸¸ç, ¿©±â¼­ ƯÁ¤ ¹ÙÀÌ¿À¸¶Ä¿´Â ÀûÀýÇÑ ´ÜŬ·ÐÇ×ü Ä¡·áÀÇ ¼±ÅÃÀ» À¯µµÇÕ´Ï´Ù. ¾Ï ´ÜŬ·ÐÇ×ü ½ÃÀåÀÌ ÁøÈ­¸¦ °è¼ÓÇϰí ÀÖ´Â °¡¿îµ¥, Çõ½ÅÀûÀÎ Ä¡·á¹ý, ¸ÂÃãÇü Ä¡·áÀÇ Áß½Ã, ±×¸®°í Áö¼ÓÀûÀÎ ¿¬±¸ÀÇ Á¶ÇÕÀÌ, ÇâÈÄÀÇ ¼ºÀåÀ» °ßÀÎÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» ¿Ï¼öÇÒ °ÍÀÔ´Ï´Ù.

¿ì¸®ÀÇ º¸°í¼­´Â °í°´¿¡°Ô ´Ù¾çÇÑ »ê¾÷ ¹× ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÌ°í ½Ç¿ëÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇϱâ À§ÇØ ¼¼½ÉÇÑÁÖÀǸ¦ ±â¿ï¿© ÀÛ¼ºµÇ¾ú½À´Ï´Ù. °¢ º¸°í¼­¿¡´Â ½ÃÀå »óȲÀ» ¿ÏÀüÈ÷ ÀÌÇØÇϱâ À§ÇØ ¸î °¡Áö Áß¿äÇÑ ¿ä¼Ò°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä : Á¤ÀÇ, ºÐ·ù, ¾÷°è ÇöȲ µî ½ÃÀå¿¡ ´ëÇÑ »ó¼¼ÇÑ ¼Ò°³

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ : ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù. ÀÌ ¼½¼Ç¿¡¼­´Â ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯°æ, »õ·Î¿î µ¿Çâ µîÀÇ ¿äÀÎÀ» È®ÀÎÇÕ´Ï´Ù.

¼¼ºÐÈ­ ºÐ¼® : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ª µîÀÇ ±âÁØ¿¡ µû¶ó ½ÃÀåÀ» ¸íÈ®ÇÑ ºÎ¹®À¸·Î ºÐ·ùÇÕ´Ï´Ù. ÀÌ ºÐ¼®Àº °¢ ºÎ¹®ÀÇ ¼º°ú¿Í ¹Ì·¡¸¦ ¹àÇôÁÝ´Ï´Ù.

°æÀï ±¸µµ : ½ÃÀå Á¡À¯À², Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê, À繫 ½ÇÀû µî ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû Æò°¡, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï ¿ªÇаú ÁÖ¿ä Àü·«¿¡ ´ëÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿¹Ãø : °ú°Å µ¥ÀÌÅÍ¿Í ÇöÀç ½ÃÀå »óȲ¿¡ µû¶ó ÀÏÁ¤ ±â°£ µ¿¾È ½ÃÀå ±Ô¸ð¿Í ¼ºÀå µ¿ÇâÀ» ¿¹ÃøÇÕ´Ï´Ù. ¿©±â¿¡´Â Á¤·®Àû ºÐ¼®°ú ÇâÈÄ ½ÃÀå ±ËÀûÀ» º¸¿©ÁÖ´Â ±×·¡ÇÁ Ç¥½Ã°¡ Æ÷ÇԵ˴ϴÙ.

Áö¿ª ºÐ¼® : Áö¿ªº° ½ÃÀå ¼º°ú¸¦ Æò°¡Çϰí ÁÖ¿ä ½ÃÀå°ú Áö¿ª µ¿ÇâÀ» ¹àÈü´Ï´Ù. Áö¿ª ½ÃÀå ¿ªÇаú ºñÁî´Ï½º ±âȸ¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

»õ·Î¿î µ¿Çâ°ú ±âȸ : ÇöÀç ½ÃÀå µ¿Çâ°ú »õ·Î¿î ½ÃÀå µ¿Çâ, ±â¼ú Çõ½Å, ÀáÀçÀûÀÎ ÅõÀÚ ´ë»ó ºÐ¾ß¸¦ ÆÄ¾ÇÇÕ´Ï´Ù. ¹Ì·¡ ½ÃÀå °³Ã´°ú ¼ºÀå Àü¸Á¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾Ï ´ÜŬ·ÐÇ×ü »ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¾Ï ´ÜŬ·ÐÇ×ü ¼¼°è ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦6Àå ¾Ï ´ÜŬ·ÐÇ×ü ¼¼°è ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦7Àå ¾Ï ´ÜŬ·ÐÇ×ü ¼¼°è ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

Á¦8Àå ¾Ï ´ÜŬ·ÐÇ×ü ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå ¾Ï ´ÜŬ·ÐÇ×ü ±â¾÷°æÀï ±¸µµ

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cancer Monoclonal Antibodies Market size is anticipated to grow from USD 110.92 Billion in 2024 to USD 525.57 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 18.87% during the forecast period of 2026 to 2033.

The cancer monoclonal antibodies market is experiencing significant growth, driven by the increasing prevalence of cancer and the rising demand for targeted therapies. Monoclonal antibodies (mAbs) are engineered proteins designed to specifically target cancer cells, offering a more precise treatment option compared to traditional chemotherapy. As healthcare providers and patients seek effective and less toxic treatment alternatives, the demand for cancer monoclonal antibodies is expected to rise, positioning this market for robust expansion. Current therapies include well-established mAbs such as trastuzumab and rituximab, as well as newer agents that target various cancer types.

Moreover, advancements in monoclonal antibody technology are propelling innovation within the market. The development of bispecific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors is revolutionizing cancer treatment by enhancing the efficacy and specificity of therapies. These innovations not only improve treatment outcomes but also minimize side effects, thereby improving the overall quality of life for patients. As research continues to explore new applications and combinations of monoclonal antibodies, the market is likely to expand further, driven by the promise of improved therapeutic options.

Additionally, the growing emphasis on personalized medicine is shaping the cancer monoclonal antibodies landscape. As healthcare providers increasingly recognize the importance of tailoring treatments to individual patient profiles based on genetic and molecular characteristics, the demand for mAbs that align with personalized treatment strategies is likely to rise. This trend is particularly relevant in the context of companion diagnostics, where specific biomarkers guide the selection of appropriate monoclonal antibody therapies. As the cancer monoclonal antibodies market continues to evolve, the combination of innovative therapies, a focus on personalized care, and ongoing research will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

By Application

By End-user

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. CANCER MONOCLONAL ANTIBODIES INDUSTRY ANALYSIS

4. VALUE CHAIN ANALYSIS

5. GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY TYPE

6. GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY APPLICATION

7. GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY END-USER

8. GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY GEOGRAPHY

9. COMPETITIVE LANDSCAPE OF THE CANCER MONOCLONAL ANTIBODIES COMPANIES

10. COMPANY PROFILES OF CANCER MONOCLONAL ANTIBODIES INDUSTRY

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â